|
|
SciBase Expands Further Through European Market with First Sales Order to customer in Italy |
|
|
SciBase reaches milestone with over 300,000 patients tested with Nevisense |
|
|
SciBase publishes the Annual report for 2024 |
|
|
Notice to attend the annual general meeting in Scibase Holding AB (publ) |
|
|
Interim report |
|
|
SciBase launches next generation Nevisense |
|
|
Year-end report |
|
|
New study shows significant improved clinical accuracy with Nevisense for both US and German dermatologists |
|
|
SciBase continues US expansion, on-boards Several US Dermatology Practices that Specialize in Skin Cancer Detection |
|
|
New review article highlights Nevisense effectiveness in identifying malignant skin lesions |
